Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

BIM Technology assists in the Latest Monobloc Cleanroom Installation

Thursday, August 31, 2017

As its largest offsite cleanroom construction project to date Connect Cleanrooms has completed the installation of a Monobloc panel system for global medical products and technologies company ConvaTec to assist with the manufacture of wound dressing...

ISCT revises cell and gene therapy industry forecast following FDA Novartis CTL019 approval

Thursday, August 31, 2017

The International Society for Cellular Therapy ISCT the global professional society of clinicians researchers regulatory specialists technologists and industry partners in the cell therapy sector today announces its revised forecast for the CART and...

Prometic Receives Rare Pediatric Disease Designation From U.S. FDA for its Plasminogen Replacement Therapy

Wednesday, August 30, 2017

Prometic Life Sciences Inc today announced that the US Food and Drug Administration FDA has granted a Rare Pediatric Disease Designation to Prometics Ryplazim a plasminogen replacement therapy for the treatment of patients with congenital plasminogen...

Boehringer Ingelheim Pharmaceuticals, Inc. receives FDA approval for Cyltezo™ (adalimumab-adbm), a biosimilar to Humira®, for the treatment of multiple chronic inflammatory diseases

Wednesday, August 30, 2017

Boehringer Ingelheim Pharmaceuticals Inc today announced that the US Food and Drug Administration FDA approved Cyltezo a biosimilar to Humira in a prefilled syringe for the treatment of multiple chronic inflammatory diseases including moderate to...

Lumosa Therapeutics Partners with Camargo Pharmaceutical Services in the Development of Naldebain(R) in the US

Tuesday, August 29, 2017

Lumosa Therapeutics Co Ltd Lumosa a Taipeibased biopharmaceutical company developing innovative therapies focused on the treatment of neurological and inflammatory disease announced today the FDA has confirmed the b regulatory pathway is appropriate...

Bristol-Myers Squibb and Daiichi Sankyo Announce Research Collaboration to Evaluate Opdivo® (nivolumab) and DS-8201 in HER2-Expressing Breast and Bladder Cancers

Tuesday, August 29, 2017

BristolMyers Squibb Company NYSEBMY and Daiichi Sankyo Company Limited hereafter Daiichi Sankyo today announced a collaborative clinical trial to evaluate the combination of BristolMyers Squibbs immunotherapy Opdivo nivolumab and Daiichi Sankyos inve...

Worldwide Clinical Trials Experts to Advance Dialogue on the Future of Clinical Research for Immune-Mediated Inflammatory Disorders

Friday, August 25, 2017

To advance exploration of uncommon approaches to clinical research and development challenges Worldwide Clinical Trials wwwworldwidecom will host the next in its series of Eavesdropping on the Experts webinars titled Exploring the Future of Clinical...

Boehringer Ingelheim initiates Phase IIa study of compound acquired from Pharmaxis in debilitating liver disease NASH

Saturday, August 26, 2017

Boehringer Ingelheim and pharmaceutical company Pharmaxis ASX PXS announce that Boehringer Ingelheim has initiated a European and North American Phase IIa trial in NASH with BI formerly known as PXSA acquired from Pharmaxis in May The compound is a...

New Somru BioScience-Radiant Pharmaceuticals Joint Venture Drives PEI Export Sales

Saturday, August 26, 2017

PEIs Somru BioScience has teamed up with Radiant Pharmaceuticals a Bangladeshi pharmaceutical powerhouse in a joint venture that will greatly improve the tools available in Bangladesh for early diagnosis of diseases like diabetes and cancerThe jo...

Roquette continues momentum with Pharmaceutical investments

Thursday, August 24, 2017

Roquette a global leader in innovative plantbased pharmaceutical ingredients continues to be on the move by opening a new facility in SingaporeOver the last few months Roquette has made several major investment announcements that will position th...